New research, guidelines and FDA decisions, each with a note on what it might change in a conversation with your surgeon, how certain it is, and links to the original sources.
How we choose news. Nothing here is sponsored. Mentioning a product isn't an endorsement, and an FDA clearance means a device was found substantially equivalent to existing ones, not proven better. Updated November 2026.
Research
Saline 'hydrodissection' gave lasting relief in a small trial
A study published in Radiology found ultrasound-guided saline hydrodissection, which uses fluid to free up the nerve, gave sustained relief in people whose carpal tunnel syndrome hadn't responded to other treatment, with fewer side effects than steroids.
What this could change in a conversation with your surgeon: It's a non-surgical option some centers offer. It's newer and less studied than surgery or injections, so ask about the evidence.
Surgery vs steroid injection: similar early results
A meta-analysis of randomized trials found carpal tunnel release and steroid injection gave similar outcomes in the first six months.
What this could change in a conversation with your surgeon: It supports trying an injection first for many people. Ask what would make surgery the better choice later.
Business, product and professional-society developments. Useful background, but less likely to change your own decision.
Technology
Ultrasound-guided and open release both worked in a large US registry
In propensity-matched patients from the industry-sponsored MISSION registry, ultrasound-guided and open carpal tunnel release both relieved symptoms. The ultrasound-guided group more often had local anesthetic only and smaller incisions; procedures took longer.
What this could change in a conversation with your surgeon: If ultrasound-guided release is offered, ask how many your surgeon has done and remember this was registry data, not a randomized trial.
